Exploring the potential of nanocarriers in antipsoriatic therapeutics
Psoriasis is an autoimmune disease characterized by erythematous, scaly patches on the skin. It can be effectively managed with topical therapies since they deliver drugs to target sites of disease efficiently and can minimize systemic side-effects while ensuring high patient compliance. However, co...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-10-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09546634.2022.2089616 |
| _version_ | 1797683506668634112 |
|---|---|
| author | Mohammad Shaif Poonam Kushwaha Shazia Usmani Supriya Pandey |
| author_facet | Mohammad Shaif Poonam Kushwaha Shazia Usmani Supriya Pandey |
| author_sort | Mohammad Shaif |
| collection | DOAJ |
| description | Psoriasis is an autoimmune disease characterized by erythematous, scaly patches on the skin. It can be effectively managed with topical therapies since they deliver drugs to target sites of disease efficiently and can minimize systemic side-effects while ensuring high patient compliance. However, conventional topical formulations are ineffective in treating psoriasis due to their poor percutaneous penetration and inability to reach deeper layers of the skin. Thus, it is important to explore new approaches for managing psoriasis safely and effectively while also maintaining patient compliance without compromising safety. Over the last few decades, a variety of nanocarriers have been extensively investigated as a new approach to delivering drugs to the skin that are effective against psoriasis. These nanocarriers are notable for their therapeutic effectiveness, increased localization of medication in the skin, and reduced side-effects. The purpose of this review is to explore the recent advances in polymer-based, lipid-based, metallic, and microneedle-based novel nanoformulations of antipsoriatic drugs. There have been detailed discussions about several nanocarrier systems including nanoemulsions, liposomes, nanostructured lipid carriers, ethosomes, solid lipid nanoparticles, micelles, gold nanoparticles, silver nanoparticles, and microneedles. In a nutshell, nanoformulations are considered a promising avenue for psoriasis treatment since they offer better penetration, targeted delivery, and enhanced safety and efficacy. |
| first_indexed | 2024-03-12T00:15:26Z |
| format | Article |
| id | doaj.art-e1f46cad360a435a900caabb91b0bd2b |
| institution | Directory Open Access Journal |
| issn | 0954-6634 1471-1753 |
| language | English |
| last_indexed | 2024-03-12T00:15:26Z |
| publishDate | 2022-10-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Dermatological Treatment |
| spelling | doaj.art-e1f46cad360a435a900caabb91b0bd2b2023-09-15T14:28:52ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532022-10-013372919293010.1080/09546634.2022.20896162089616Exploring the potential of nanocarriers in antipsoriatic therapeuticsMohammad Shaif0Poonam Kushwaha1Shazia Usmani2Supriya Pandey3Faculty of Pharmacy, Integral UniversityFaculty of Pharmacy, Integral UniversityFaculty of Pharmacy, Integral UniversityFaculty of Pharmacy, Integral UniversityPsoriasis is an autoimmune disease characterized by erythematous, scaly patches on the skin. It can be effectively managed with topical therapies since they deliver drugs to target sites of disease efficiently and can minimize systemic side-effects while ensuring high patient compliance. However, conventional topical formulations are ineffective in treating psoriasis due to their poor percutaneous penetration and inability to reach deeper layers of the skin. Thus, it is important to explore new approaches for managing psoriasis safely and effectively while also maintaining patient compliance without compromising safety. Over the last few decades, a variety of nanocarriers have been extensively investigated as a new approach to delivering drugs to the skin that are effective against psoriasis. These nanocarriers are notable for their therapeutic effectiveness, increased localization of medication in the skin, and reduced side-effects. The purpose of this review is to explore the recent advances in polymer-based, lipid-based, metallic, and microneedle-based novel nanoformulations of antipsoriatic drugs. There have been detailed discussions about several nanocarrier systems including nanoemulsions, liposomes, nanostructured lipid carriers, ethosomes, solid lipid nanoparticles, micelles, gold nanoparticles, silver nanoparticles, and microneedles. In a nutshell, nanoformulations are considered a promising avenue for psoriasis treatment since they offer better penetration, targeted delivery, and enhanced safety and efficacy.http://dx.doi.org/10.1080/09546634.2022.2089616psoriasispathogenesisnanotherapeuticsliposomehydrogelmetallic nanoparticles |
| spellingShingle | Mohammad Shaif Poonam Kushwaha Shazia Usmani Supriya Pandey Exploring the potential of nanocarriers in antipsoriatic therapeutics Journal of Dermatological Treatment psoriasis pathogenesis nanotherapeutics liposome hydrogel metallic nanoparticles |
| title | Exploring the potential of nanocarriers in antipsoriatic therapeutics |
| title_full | Exploring the potential of nanocarriers in antipsoriatic therapeutics |
| title_fullStr | Exploring the potential of nanocarriers in antipsoriatic therapeutics |
| title_full_unstemmed | Exploring the potential of nanocarriers in antipsoriatic therapeutics |
| title_short | Exploring the potential of nanocarriers in antipsoriatic therapeutics |
| title_sort | exploring the potential of nanocarriers in antipsoriatic therapeutics |
| topic | psoriasis pathogenesis nanotherapeutics liposome hydrogel metallic nanoparticles |
| url | http://dx.doi.org/10.1080/09546634.2022.2089616 |
| work_keys_str_mv | AT mohammadshaif exploringthepotentialofnanocarriersinantipsoriatictherapeutics AT poonamkushwaha exploringthepotentialofnanocarriersinantipsoriatictherapeutics AT shaziausmani exploringthepotentialofnanocarriersinantipsoriatictherapeutics AT supriyapandey exploringthepotentialofnanocarriersinantipsoriatictherapeutics |